Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NATRECOR
- Nesiritide and Renal Function After the Total Artificial Heart
- Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
- Nesiritide in Resistant Hypertension
- Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
- Nesiritide - Dilated Cardiomyopathy
- Evaluation of Combined Action Between Natrecor and Furosemide on Kidney and Neurohormone Responses in Chronic Heart Failure: A Phase-IV study704.351 / DSS
- Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction
- Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery
- Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF
- BNP Therapy Observation Unit Outcomes STudy (BOOST)
- Human B-type Natriuretic Peptide (BNP) (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
- Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
- Natriuretic Peptide System as Therapy in Human Preclinical Left Ventricle Dysfunction
- Use of Nesiritide (BNP) in Kidney Function in Patients With Congestive Heart Failure (CHF) and Kidney Failure
- Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
- A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
- Nesiritide Use Following Cardiac Surgery in Infants
- A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and
- A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure
- A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy
- A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.
- FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for
- BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling
- Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
- Nesiritide and Vo2 Max in Heart Failure Patients
- Natrecor for Pulmonary Hypertension in Lung Transplants
- BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
- Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
- Nesiritide in Chronic Heart Failure
- Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
- A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure
- Use of Nesiritide in the Management of Acute Diastolic Heart Failure
- Natrecor in Pulmonary Hypertension
Clinical trials list
click for details